Introduction

Prostacel Injection contains alprostadil, a medicine that is used in specific medical situations to improve blood flow. Alprostadil is a synthetic form of prostaglandin E1, a naturally occurring substance in the body that helps relax blood vessels. Depending on the formulation and clinical setting, it may be used for erectile dysfunction or in newborn babies with certain serious heart conditions where maintaining blood flow through the ductus arteriosus is necessary.

Mechanism of Action

Alprostadil works by relaxing the smooth muscles in blood vessel walls. This causes the blood vessels to widen and allows blood to flow more easily.

When used for erectile dysfunction, alprostadil increases blood flow into the erectile tissue of the penis, helping produce an erection. When used in newborns with certain congenital heart conditions, it helps keep the ductus arteriosus open, supporting blood circulation until further treatment can be provided.

Uses

Prostacel Alprostadil Injection may be used for:

• Treatment of erectile dysfunction in selected patients when prescribed in an appropriate formulation and route
• Improving penile blood flow in men who have difficulty achieving or maintaining an erection
• Maintaining the ductus arteriosus in newborn babies with certain congenital heart defects, when used under specialist hospital care
• Supporting circulation in critical congenital heart conditions while the infant is awaiting definitive treatment

The specific dose and route of administration depend on the medical condition and formulation, and treatment should be supervised by a healthcare professional.

Adverse Effects

Prostacel Alprostadil may cause side effects depending on how it is administered. Some individuals may experience:

• Headache or dizziness
• Flushing or a feeling of warmth
• Low blood pressure
• Nausea or stomach discomfort
• Pain or irritation at the injection site
• Penile pain or prolonged erection when used for erectile dysfunction
• Fast or irregular heartbeat in some cases
• Breathing difficulties, fever, or changes in blood pressure in newborns receiving intravenous treatment